Susceptibility weighted imaging at ultra high magnetic field strengths: Theoretical considerations and experimental results
Abstract:We present numerical simulations and experimental results for susceptibility weighted imaging (SWI) at 7 T. Magnitude, phase, and SWI contrast were simulated for different voxel geometries and imaging parameters, resulting in an echo time of 14 msec for optimum contrast between veins and surrounding tissue. Slice thickness of twice the in‐plane voxel size or more resulted in optimum vessel visibility. Phantom and in vivo data are in very good agreement with the simulations and the delineation of vessels at 7 T was superior compared to lower field strengths. The phase of the complex data reveals anatomical details that are complementary to the corresponding magnitude images. Susceptibility weighted imaging at very high field strengths is a promising technique because of its high sensitivity to tissue susceptibility, its low specific absorption rate, and the phase's negligible sensitivity to B1 inhomogeneities. Magn Reson Med 60:1155–1168, 2008. © Wiley‐Liss, Inc.
暂无分享,去 创建一个
[1] M. Bronskill,et al. T1, T2 relaxation and magnetization transfer in tissue at 3T , 2005, Magnetic resonance in medicine.
[2] Rudolf Stollberger,et al. Automated unwrapping of MR phase images applied to BOLD MR‐venography at 3 Tesla , 2003, Journal of magnetic resonance imaging : JMRI.
[3] J W Langston,et al. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. , 1999, Magnetic resonance imaging.
[4] J R Reichenbach,et al. High-Resolution MR Venography at 3.0 Tesla , 2000, Journal of computer assisted tomography.
[5] Jaladhar Neelavalli,et al. Clinical applications of neuroimaging with susceptibility‐weighted imaging , 2005, Journal of magnetic resonance imaging : JMRI.
[6] R. Weisskoff,et al. MRI susceptometry: Image‐based measurement of absolute susceptibility of MR contrast agents and human blood , 1992, Magnetic resonance in medicine.
[7] J. Reichenbach,et al. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T , 1997, European Radiology.
[8] D. Noll,et al. Homodyne detection in magnetic resonance imaging. , 1991, IEEE transactions on medical imaging.
[9] Iwao Kanno,et al. Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[10] P. Boesiger,et al. SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.
[11] Jan Sedlacik,et al. Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels , 2007, Magnetic resonance in medicine.
[12] Jeff H. Duyn,et al. High-field MRI of brain cortical substructure based on signal phase , 2007, Proceedings of the National Academy of Sciences.
[13] F. A. Seiler,et al. Numerical Recipes in C: The Art of Scientific Computing , 1989 .
[14] A. Shmuel,et al. Imaging brain function in humans at 7 Tesla , 2001, Magnetic resonance in medicine.
[15] Weili Lin,et al. In vivo validation of the bold mechanism: A review of signal changes in gradient echo functional MRI in the presence of flow , 1995, Int. J. Imaging Syst. Technol..
[16] P. Roemer,et al. The NMR phased array , 1990, Magnetic resonance in medicine.
[17] E. Haacke,et al. High‐resolution BOLD venographic imaging: a window into brain function , 2001, NMR in biomedicine.
[18] D. Yablonskiy,et al. Water proton MR properties of human blood at 1.5 Tesla: Magnetic susceptibility, T1, T2, T *2 , and non‐Lorentzian signal behavior , 2001, Magnetic resonance in medicine.
[19] K. Uğurbil,et al. Spin‐echo fMRI in humans using high spatial resolutions and high magnetic fields , 2003, Magnetic resonance in medicine.
[20] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[21] X Golay,et al. Comparison of the dependence of blood R2 and R 2* on oxygen saturation at 1.5 and 4.7 Tesla , 2003, Magnetic resonance in medicine.
[22] K. Uğurbil,et al. Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo , 2007, Magnetic resonance in medicine.
[23] Lothar R. Schad,et al. High-resolution venography of the brain using magnetic resonance imaging , 1998, Magnetic Resonance Materials in Physics, Biology and Medicine.
[24] Chandrasekharan Kesavadas,et al. Clinical applications of susceptibility weighted MR imaging of the brain – a pictorial review , 2008, Neuroradiology.
[25] J. Hogg. Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.
[26] Petra Schmalbrock,et al. Blipped multi gradient‐echo slice excitation profile imaging (bmGESEPI) for fast T 2* measurements with macroscopic B0 inhomogeneity compensation , 2006, Magnetic resonance in medicine.
[27] J. Reichenbach,et al. Magnetic susceptibility-weighted MR phase imaging of the human brain. , 2005, AJNR. American journal of neuroradiology.
[28] C. S. Springer,et al. Physicochemical Principles Influencing Magnetopharmaceuticals , 1994 .
[29] J R Reichenbach,et al. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.
[30] P. Lundberg,et al. Novel method for rapid, simultaneous T1, T*2, and proton density quantification , 2007, Magnetic resonance in medicine.
[31] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.
[32] J. Mintorovitch,et al. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.
[33] Jeff H. Duyn,et al. Extensive heterogeneity in white matter intensity in high-resolution T2 *-weighted MRI of the human brain at 7.0 T , 2006, NeuroImage.
[34] Max A. Viergever,et al. MR venography of the human brain using susceptibility weighted imaging at very high field strength , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[35] Richard Bowtell,et al. T2* measurements in human brain at 1.5, 3 and 7 T. , 2007, Magnetic resonance imaging.
[36] K. Uğurbil,et al. Determination of blood longitudinal relaxation time (T1) at high magnetic field strengths. , 2007, Magnetic resonance imaging.
[37] Peter C M van Zijl,et al. Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T , 2007, Magnetic resonance in medicine.
[38] Mark E Ladd,et al. High-Field-Strength Magnetic Resonance: Potential and Limits , 2007, Topics in magnetic resonance imaging : TMRI.
[39] Yingbiao Xu,et al. The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. , 2006, Magnetic resonance imaging.
[40] Petra Schmalbrock,et al. Enhanced gray and white matter contrast of phase susceptibility‐weighted images in ultra‐high‐field magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.
[41] J. Reichenbach,et al. Theory and application of static field inhomogeneity effects in gradient‐echo imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[42] T E Conturo,et al. Signal‐to‐noise in phase angle reconstruction: Dynamic range extension using phase reference offsets , 1990, Magnetic resonance in medicine.
[43] Yu-Chung N. Cheng,et al. Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.
[44] Jaladhar Neelavalli,et al. Susceptibility‐weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses , 2006, Journal of magnetic resonance imaging : JMRI.
[45] E. Haacke,et al. Susceptibility-Weighted MR Imaging: A Review of Clinical Applications in Children , 2008, American Journal of Neuroradiology.